S

Susmed Inc
TSE:4263

Watchlist Manager
Susmed Inc
TSE:4263
Watchlist
Price: 899 JPY -2.07% Market Closed
Market Cap: 15.2B JPY

Susmed Inc
Cost of Revenue

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Susmed Inc
Cost of Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
S
Susmed Inc
TSE:4263
Cost of Revenue
-ÂĄ12.3m
CAGR 3-Years
-6%
CAGR 5-Years
-51%
CAGR 10-Years
N/A
M3 Inc
TSE:2413
Cost of Revenue
-ÂĄ145.2B
CAGR 3-Years
-17%
CAGR 5-Years
-19%
CAGR 10-Years
-21%
EM Systems Co Ltd
TSE:4820
Cost of Revenue
-ÂĄ11.8B
CAGR 3-Years
-15%
CAGR 5-Years
-11%
CAGR 10-Years
-9%
S
Software Service Inc
TSE:3733
Cost of Revenue
-ÂĄ28.1B
CAGR 3-Years
-14%
CAGR 5-Years
-12%
CAGR 10-Years
-10%
Medley Inc
TSE:4480
Cost of Revenue
-ÂĄ10.4B
CAGR 3-Years
-39%
CAGR 5-Years
-46%
CAGR 10-Years
N/A
JMDC Inc
TSE:4483
Cost of Revenue
-ÂĄ20.2B
CAGR 3-Years
-25%
CAGR 5-Years
-27%
CAGR 10-Years
N/A
No Stocks Found

Susmed Inc
Glance View

Market Cap
15.1B JPY
Industry
Health Care

SUSMED, Inc. engages in the development of medical equipment and software systems. The company is headquartered in Chuo-Ku, Tokyo-To. The company went IPO on 2021-12-24. The firm operates through two business segments. The DTx Product segment is engaged in the development of application software products for treating diseases such as insomnia, breast cancer, chronic kidney diseases and others. The DTx Platform segment is engaged in the provision of general-purpose clinical trial systems and machine learning automatic analysis systems, as well as the provision of DTx development support services using systems.

Intrinsic Value
638.69 JPY
Overvaluation 29%
Intrinsic Value
Price
S

See Also

What is Susmed Inc's Cost of Revenue?
Cost of Revenue
-12.3m JPY

Based on the financial report for Jun 30, 2025, Susmed Inc's Cost of Revenue amounts to -12.3m JPY.

What is Susmed Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-51%

Over the last year, the Cost of Revenue growth was -5%. The average annual Cost of Revenue growth rates for Susmed Inc have been -6% over the past three years , -51% over the past five years .

Back to Top